19 opportunities found using the current filters, sorted by opening date
UKRI and RCN have signed a Money Follows Cooperation agreement to enable collaborative applications between researchers in the UK and Norway. UKRI funding will be provided for co-investigators from Norway in successful applications.
Conditions will differ depending on the funding opportunity.
Apply for funding to research myalgic encephalomyelitis/chronic fatigue syndrome, also known as ME/CFS.
Apply for funding to research motor neurone disease (MND).
You can get funding through any:
You should apply through the existing funding opportunity that is most relevant to your science area and career stage.
Apply for funding for the application of artificial intelligence (AI), engineering biology, and quantum technologies in biomedical research and development.
You must be based at a UK research organisation eligible for MRC funding.
Apply for funding to investigate the causes, progression and treatment of human disease. Your application must include an intervention in humans.
You must be based at an eligible research organisation. Researchers transitioning to independence may be eligible to apply as a ‘new investigator’.
Apply for MRC Centre of Research Excellence (MRC CoRE) funding to tackle complex and interdisciplinary health challenges.
You must be based at a UK research organisation eligible for MRC funding.
Apply for support to become an independent researcher in a medical research field.
Your research can focus on any area of Medical Research Council’s (MRC) remit to improve human health.
You must:
Apply for funding to reacquire research skills.
Your research can focus on any area of Medical Research Council (MRC)’s remit to improve human health.
You must:
Apply for funding to undertake a PhD.
Your research can focus on any area of Medical Research Council (MRC)’s remit to improve human health.
You must:
Apply for funding to run a High Throughput Screen (HTS) using AstraZeneca’s compound library and screening robots.
Two funding opportunities per year with changing highlights. This funding opportunity will have a highlight on new targets related to autoimmunity or motor neurone disease.
